The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
Open accessPublished version of a preprint
Abstract
Peritoneal metastases are the leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC). Accumulating evidence suggests that mesothelial cells are an important component of the metastatic microenvironment in HGSOC. However, the mechanisms by which mesothelial cells promote metastasis are unclear. Here, we report that the HGSOC tumor-mesothelial niche was hypoxic, and hypoxic signaling enhanced collagen I deposition by mesothelial cells. Specifically, hypoxic signaling increased expression of lysyl oxidase (LOX) in mesothelial and ovarian cancer cells to promote collagen crosslinking and tumor cell invasion. The mesothelial niche was enriched with fibrillar collagen in human and murine omental metastases. Pharmacologic inhibition of LOX reduced tumor burden and collagen remodeling in murine omental metastases. These findings highlight an important role for hypoxia and mesothelial cells in the modification of the extracellular matrix and tumor invasion in HGSOC. Significance: This study identifies HIF/LOX signaling as a potential therapeutic target to inhibit collagen remodeling and tumor progression in HGSOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, collagen interaction with other ECM molecules including fibronectin, laminin, hyaluronic acid, and MMPs influences cancer cell activity [127].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [127]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S. K., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 473
RetractedHypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Junqueira, L. C. U., Bignolas, G., & Brentani, H. (1979) · The Histochemical Journal · doi:10.1007/bf01002772 · Cited by 2,570
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,098
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,791
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D. L., Böhm, S., Ahmed, A. A., Aspuria, P.-J. P., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S. P., Bookman, M. A., et al. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4019 · Cited by 1,395
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · cited 5×
“Further knowledge regarding the role of HIF signaling in mediating tumor–stromal interactions within specific metastatic TME is needed to understand how to best target the hypoxic TME for cancer therapy.”
BackgroundInfluentialSelf-citation
Cited by
Sorted by citations
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Moreover, collagen interaction with other ECM molecules including fibronectin, laminin, hyaluronic acid, and MMPs influences cancer cell activity [127] .”
BackgroundYuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T. M., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 307
Lin, Z., Song, J., Gao, Y., Huang, S., Dou, R., Zhong, P., Huang, G., Han, L., Zheng, J., Zhang, X., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102312 · Cited by 249
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Schoutrop, E., Moyano‐Galceran, L., Lheureux, S., Mattsson, J., Lehti, K., Dahlstrand, H. M., & Magalhaes, I. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.027 · Cited by 181
Co-evolution of Matrisome and Adaptive Adhesion Dynamics Drives Ovarian Cancer Chemoresistance
Pietilä, E. A., Gonzalez-Molina, J., Moyano-Galceran, L., Jamalzadeh, S., Zhang, K., Lehtinen, L., Turunen, S. P., Martins, T. A., Gultekin, O., Lamminen, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24009-8 · Cited by 175
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 162
Qian, J., LeSavage, B. L., Hubka, K. M., Ma, C., Natarajan, S., Eggold, J. T., Xiao, Y., Fuh, K. C., Krishnan, V., Enejder, A. M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146186 · Cited by 132
Self-citationGlycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 135
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 125
Tumor microenvironment in ovarian cancer peritoneal metastasis
Mei, S., Chen, X., Wang, K., & Chen, Y. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02854-5 · Cited by 112
Targeting the immune microenvironment for ovarian cancer therapy
Blanc‐Durand, F., Xian, L. C. W., & Tan, D. S. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1328651 · Cited by 115
Krishnan, V., Tallapragada, S., Schaar, B. T., Kamat, K., Chanana, A. M., Zhang, Y., Patel, S. A., Parkash, V., Rinker-Schaeffer, C. W., Folkins, A. K., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01246-z · Cited by 107
Self-citationEvolving roles of lysyl oxidase family in tumorigenesis and cancer therapy
Ye, M., Song, Y., Pan, S., Chu, M., Wang, Z. P., & Zhu, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107633 · Cited by 89
Mechanical signatures in cancer metastasis
Agrawal, A., Javanmardi, Y., Watson, S. A., Serwinski, B., Djordjevic, B., Li, W., Aref, A. R., Jenkins, R. W., & Moeendarbary, E. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00007-x · Cited by 89
Zhang, Q., An, Z.-Y., Jiang, W. G., Jin, W., & He, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115390 · Cited by 79
Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
Amendola, P. G., Reuten, R., & Erler, J. T. (2019) · Cancers · doi:10.3390/cancers11050729 · Cited by 76
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
Zeltz, C., Pasko, E., Cox, T. R., Navab, R., & Tsao, M. (2019) · Cancers · doi:10.3390/cancers11050705 · Cited by 72
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
Huang, Y., Liang, C.-Y., Ritz, D., Coelho, R., Septiadi, D., Estermann, M., Cumin, C., Rimmer, N., Schötzau, A., López, M. N., et al. (2020) · eLife · doi:10.7554/elife.59442 · Cited by 71
Yamauchi, M., Gibbons, D. L., Zong, C. C., Fradette, J. J., Bota‐Rabassedas, N., & Kurie, J. M. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.001 · Cited by 67
Zhong, C., Tao, B., Tang, F., Yang, X., Peng, T., You, J., Xia, K., Xia, X., Chen, L., & Peng, L. (2020) · Theranostics · doi:10.7150/thno.50613 · Cited by 64
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer
Wang, W., Wang, X., Yao, F., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012270 · Cited by 63
Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
Yang, N., Cao, D., Yin, X., Zhou, H., & Mao, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110791 · Cited by 61
Liang, Y., Xia, W., Zhang, T., Chen, B., Wang, H., Song, X., Zhang, Z., Xu, L., Dong, G., & Jiang, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573534 · Cited by 56
Wang, X., Che, X., Yu, Y., Cheng, Y., Bai, M., Yang, Z., Guo, Q., Xie, X., Li, D., Guo, M., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01703-x · Cited by 55
Chai, C., Liang, L., Mikkelsen, N. S., Wang, W., Zhao, W., Sun, C., Bak, R. O., Li, H., Lin, L., Wang, F., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05826-1 · Cited by 57
Yang, Y., Wang, Y., Ahn, J., Kim, B., & Choi, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113474 · Cited by 52
Li, H., Zeng, C., Shu, C., Cao, Y., Shao, W.-G., Zhang, M., Cao, H., & Zhao, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05472-7 · Cited by 50
Bajwa, P., Kordylewicz, K., Bilecz, A. J., Lastra, R. R., Wroblewski, K., Rinkevich, Y., Lengyel, E. R., & Kenny, H. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163019 · Cited by 49
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
Wang, X., Du, Z., Xu, T., Wang, X., Li, W., Gao, J., Li, J., & Zhu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.785111 · Cited by 50
Kaemmerer, E., Loessner, D., & Avery, V. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.030 · Cited by 48
Brown, Y., Hua, S., & Tanwar, P. S. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.02.004 · Cited by 47
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
Tadić, V., Zhang, W., & Brozović, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189052 · Cited by 43
Expression of LOX Suggests Poor Prognosis in Gastric Cancer
Zhu, J., Luo, C. H., Zhao, J., Zhu, X., Kang, L., Bu, F., Yu, Z., Zou, F., & Zhu, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.718986 · Cited by 40
Uno, K., Iyoshi, S., Yoshihara, M., Kitami, K., Mogi, K., Fujimoto, H., Sugiyama, M., Koya, Y., Yamakita, Y., Nawa, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084383 · Cited by 36
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
Wang, Y., Zhu, N., Liu, J., Chen, F., Song, Y., Ma, Y., Yang, Z., & Wang, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06508-0 · Cited by 44
Shaikat, A. H., Azad, S. M. A. K., Tamim, M. A. R., Ullah, M. S., Amin, M. N., Sabbir, M. K., Tarun, M. T. I., Mostaq, M. S., Sabrin, S., Mahmud, M. Z., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.07.003 · Cited by 37
Giamougiannis, P., Morais, C. L. M., Grabowska, R., Ashton, K. M., Wood, N. J., Martin‐Hirsch, P. L., & Martin, F. L. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-03045-1 · Cited by 35
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 38
Fujimoto, H., Yoshihara, M., Rodgers, R. J., Iyoshi, S., Mogi, K., Miyamoto, E., Hayakawa, S., Hayashi, M., Nomura, S., Kitami, K., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10169-8 · Cited by 29
The prognostic value of the lysyl oxidase family in ovarian cancer
Ye, M., Zhou, J., Gao, Y., Pan, S., & Zhu, X. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23538 · Cited by 30
Han, L., Xu, S., Zhou, D., Chen, R., Ding, Y., Zhang, M., Bao, M., He, B., & Li, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401648 · Cited by 29
Lian, X., Zhang, H., Liu, Q., Lu, X. M., Zhou, P., He, S., Tang, R., & Cui, J. (2020) · 癌症:英文版 · doi:10.1002/cac2.12034 · Cited by 28
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
Hilliard, T. S., Kowalski, B., Iwamoto, K., Agadi, E., Liu, Y., Yang, J., Asem, M., Klymenko, Y., Johnson, J. J., Shi, Z., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212443 · Cited by 27
García‐Olmo, D., Villarejo‐Campos, P., Barambio, J., Gómez‐Heras, S. G., Vega-Clemente, L., López, S. O., Guadalajara, H., & García‐Arranz, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79721-0 · Cited by 26
Schab, A. M., Greenwade, M. M., Stock, E. C., Lomonosova, E., Cho, K., Grither, W. R., Noia, H. M., Wilke, D., Mullen, M. M., Hagemann, A. R., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0347 · Cited by 26
Self-citationThe role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Zheng, A., Wei, Y., Zhao, Y., Zhang, T., & Ma, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013506 · Cited by 25
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 25
Kanniyappan, H., Rathnayake, R. A. C., Osamor, J., Islam, M., & Wang, R. R. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1679625 · Cited by 30
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 28
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?
Mendes, A. D., Freitas, A. R., Vicente, R. S., Vitorino, M. M., Batista, M. V., Silva, M., & Braga, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316589 · Cited by 24
Waters, J. A., Robinson, M., Lujano-Olazaba, O., Lucht, C., Gilbert, S. F., & House, C. D. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2613 · Cited by 20
Zhang, Q., Wu, L., Liu, S., Chen, Q., Zeng, L., Chen, X., & Zhang, Q. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac07d1 · Cited by 19
Bileck, A., Bortel, P., Kriz, M., Janker, L., Kiss, E., Gerner, C., & Favero, G. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.746411 · Cited by 19
The intriguing role of collagen on the rheology of cancer cell spheroids
Tsvirkun, D., Révilloud, J., Giannetti, A., & Claude Verdier, A. (2022) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2022.111229 · Cited by 18
Tumor-initiating cells establish a niche to overcome isolation stress
Wu, C., Weis, S. M., & Cheresh, D. A. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.08.001 · Cited by 14
Improving targeted small molecule drugs to overcome chemotherapy resistance
Rismanbaf, A. (2023) · Cancer Reports · doi:10.1002/cnr2.1945 · Cited by 14
The role of the LOX family in cancer
Boaru, D. L., León-Oliva, D. D., Fraile‐Μartinez, O., Castro-Martinez, P. D., Montero, C. G., Ferrara-Coppola, C., Alhaddadin, M. N. M., Barrena-Blázquez, S., Peñas-González, C. D. L., Holgado-Tirado, N., et al. (2025) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2025.151527 · Cited by 13
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
Clemente-González, C., & Carnero, A. (2022) · Cancers · doi:10.3390/cancers14235930 · Cited by 13
Ma, J., To, S. K. Y., Fung, K. S. W., Wang, K., Zhang, J., Ngan, A. H. W., Yung, S., Chan, T. M., Wong, C. C., Ip, P. P. C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115096 · Cited by 12
Valmiki, S., Aid, M., Chaitou, A. R., Zahid, M., Valmiki, M., Fawzy, P., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.13864 · Cited by 12
Rio, D. D., Masi, I., Caprara, V., Spadaro, F., Ottavi, F., Strippoli, R., Sandoval, P., López‐Cabrera, M., de la Cuesta, R. S., Bagnato, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764375 · Cited by 12
Wang, B., Shan, C., & Guo, B. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24165 · Cited by 11
Liang, R., Yung, M. M. H., He, F., Jiao, P., Chan, K. K. L., Ngan, H., & Chan, D. W. (2021) · Cancers · doi:10.3390/cancers13184577 · Cited by 12
Akanda, M. R., Lubaba, U., Rahman, M. K., Islam, A., Akter, M., Islam, M. S., Uddin, M. N., & Park, B. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155918 · Cited by 10
Ostrowska-Leśko, M., Rajtak, A., Moreno‐Bueno, G., & Bobiński, M. S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189036 · Cited by 10
Launonen, I.-M. P., Vähärautio, A., & Färkkilä, A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041314 · Cited by 10
Nagashima, J. B., Zenilman, S. S., Raab, A., Aranda‐Espinoza, H., & Songsasen, N. (2023) · Bioengineering · doi:10.3390/bioengineering10111285 · Cited by 9
Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer
Gonda, A., Zhao, N., Shah, J. V., Siebert, J. N., Gunda, S., Inan, B., Kwon, M., Libutti, S. K., Moghe, P. V., Francis, N. L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718408 · Cited by 9
Application Of Adoptive Immunotherapy In Ovarian Cancer
Yang, S., Yin, X., Yue, Y., & Wang, S. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s221773 · Cited by 12
Bochner, F., Fellus-Alyagor, L., Ketter, D., Golani, O., Biton, I. E., & Neeman, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0878-7 · Cited by 9
Collagen synthesis and gap junctions: the highway for metastasis of ovarian cancer
Lyu, Y., & Feng, C. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00546-0 · Cited by 8
Tissue Rigidity Increased during Carcinogenesis of NTCU-Induced Lung Squamous Cell Carcinoma In Vivo
Zakaria, M. A., Aziz, J., Rajab, N. F., Chua, E. W., & Masre, S. F. (2022) · Biomedicines · doi:10.3390/biomedicines10102382 · Cited by 7
Zhang, S. (2022) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2022.263 · Cited by 7
The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
Laasik, M., Hynninen, J., Forsback, S. J., Noponen, T., Seppänen, M., & Hietanen, S. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00689-z · Cited by 7
Lama-Sherpa, T. D., Das, S., Hinshaw, D. C., Kammerud, S. C., Song, P. N., Alsheikh, H. A., Sorace, A. G., Samant, R. S., & Shevde, L. A. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0257 · Cited by 6
Grillo, E., Ravelli, C., Corsini, M., Domenichini, M., Scamozzi, M., Zizioli, D., Capoferri, D., Bresciani, R., Romani, C., & Mitola, S. M. F. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151459 · Cited by 5
Kumari, S., Patro, A. R. K., Mishra, B., Jena, S. K., & Singh, S. (2021) · Diagnostics · doi:10.3390/diagnostics12010053 · Cited by 5
Fisher, M., Duhon, B. H., Nguyen, H. T. N., Tonniges, J. R., Wu, K. C., & Ren, Y. (2024) · Otolaryngology · doi:10.1002/ohn.1018 · Cited by 4
Uno, K., Yoshihara, M., Yamakita, Y., Kitami, K., Iyoshi, S., Sugiyama, M., Koya, Y., Kanayama, T., Sahara, H., Nomura, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adu5944 · Cited by 4
Hart, P. C., Bajwa, P., & Kenny, H. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73359-9_5 · Cited by 3
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Chaudhary, B., Kumar, P., Arya, P., Singla, D., Kumar, V., Kumar, D., Roshan, S., Wadhwa, S., Gulati, M., Singh, S. K., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666230110145513 · Cited by 4
Wang, J., Chen, Z., Zhao, P., Wang, Y., Chen, J., & Lin, Q. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03077-0 · Cited by 4
Gonzalez‐Molina, J., Nabili, P., Marciano, D., Abdelnabi, S., Gultekin, O., Rasul, M. F., Zhang, Y., Nadal, C., Chrysanthou, A., Alkasalias, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62296-7 · Cited by 5
Hua, M., Chen, Y., Jia, M., Lv, W., Xu, Y., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33201 · Cited by 3
Han, X., Caron, J. M., Lary, C. W., Sathyanarayana, P., Vary, C., & Brooks, P. C. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.009 · Cited by 3
Expression of Amine Oxidase Proteins in Adrenal Cortical Neoplasm and Pheochromocytoma
Kim, E. K., & Koo, J. S. (2023) · Biomedicines · doi:10.3390/biomedicines11071896 · Cited by 3
Krawiec, A., Pietrasik, J., Pietrasik, Z., Mikuła‐Pietrasik, J., & Książek, K. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111843 · Cited by 3
García‐Arranz, M., Villarejo‐Campos, P., Barambio, J., Gómez‐Heras, S. G., Vega-Clemente, L., Guadalajara, H., & García‐Olmo, D. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02524-2 · Cited by 3
Qi, Y., Zhang, W., Li, X., Shi, Y., & Qu, P. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101740 · Cited by 2
Natarajan, S., Nguyen, K. D. P., Li, H., Saputra, E. C., Li, C., Kim, G., Liu, Y., Sun, H., Ramli, M. N., Li, L., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-1121 · Cited by 2
Self-citationSurti, M., Gupta, A., Janiyani, K., Adnan, M., & Patel, M. B. (2026) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2026.01.009 · Cited by 2
Malacrida, B., Elorbany, S., Laforêts, F., Karim, F., Bryan-Ravenscroft, R. C., Sideris, M. C., Joy, J. D., Kotantaki, P., Skingsley, S. L. P., Heath, O. M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70398-z · Cited by 2
Expression of amine oxidase-related proteins in breast phyllodes tumor.
Kim, H. M., & Koo, J. S. (2025) · PubMed · doi:10.14670/hh-18-773 · Cited by 2
Wei, W., Zhang, Y., Li, Y., Huang, J., Kang, F., Tan, S., Lin, L., Lu, X., Wei, H., & Wang, N. (2025) · International Journal of Cancer · doi:10.1002/ijc.35387 · Cited by 2
Models of High-Grade Serous Ovarian CarcinomaPreprint
Pundel, O. J., & Neel, B. G. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041949 · Cited by 2
Wei, G., Zhu, X., Chen, X. S., Lv, J., Xiang, F., Zhang, M., Tao, K. X., Wen, W., He, D., Wu, X., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2700024 · Cited by 1
Tumor Microenvironment Complexity: A Pathological Milieu that Innately Modulates Cancer Progression
Balahura, L.-R., Lazăr, A. D., Dinescu, S., & Costache, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_89-1 · Cited by 2
Non-Invasive and Real-Time Monitoring of the Breast Cancer Metastasis Degree via Metabolomics
Zhu, W., Qian, W., Liao, W., Huang, X., Xu, J., Qu, W., Xue, J., Feng, F., Liu, W., Liu, F., et al. (2022) · Cancers · doi:10.3390/cancers14225589 · Cited by 1
Metadata
- Authors
- Natarajan, S., Foreman, K. M., Soriano, M. I., Rossen, N. S., Shehade, H., Fregoso, D. R., Eggold, J. T., Krishnan, V., Dorigo, O., Krieg, A. J., Heilshorn, S. C., Sinha, S., Fuh, K. C., & Rankin, E. B.
- Affiliations
- Stanford University (US)
- Oregon Health & Science University (US)
- SRI International (US)
- Washington University in St. Louis (US)
- Corresponding author
- Rankin, Erinn B.
- ORCID
- Venue
- Cancer Research
- Published
- 2019-05-01
- Volume
- 79
- Issue
- 9
- Pages
- 2271-2284
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC6822898
- OpenAlex
- W2921266140
- Cited by
- 129
- References
- 54
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 15 · 2023: 18 · 2022: 20 · 2021: 20 · 2020: 24 · 2019: 3
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Defense for Health Affairs (W81XWH-15-1-0097)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- high-grade serous ovarian cancer, peritoneal carcinomatosis, mesothelial cells, hypoxia, collagen remodeling, collagen I deposition, lysyl oxidase, collagen cross-linking, extracellular matrix, tumor invasion, HIF signaling, omental metastases, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adult, Aged, Aged, 80 and over, Animals, Hypoxia, Collagen, Epithelium, Extracellular Matrix, Female, Humans, Protein-Lysine 6-Oxidase, Middle Aged, Ovarian Neoplasms, Peritoneal Neoplasms, Prognosis, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice, SCID, Mice, Inbred NOD, Apoptosis, Cystadenocarcinoma, Serous, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review